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Abstract 
The Australian Government's National Bowel Cancer Screening Program (NBCSP) was introduced in 
2006 to provide free home-based immunochemical faecal occult blood test (iFOBT) to eligible 
Australians turning 55 and 65 years in that year. With the gradual inclusion of additional age cohorts, 
the rollout of the NBCSP is being implemented in the context of a degree of opportunistic screening 
being provided through primary care physicians.  
This study investigated factors associated with ever-uptake of the NBCSP and of any CRC screening 
using questionnaire data from Australians aged ≥45 years enrolled in the 45 and Up Study.  
Of the 91,968 study participants with information on CRC screening behaviour, 70,444 (76.6%) 
reported ever-uptake of any CRC screening. 63,777 study participants were eligible for a NBCSP 
invitation, of these 33,148 (52.0%) reported ever-uptake of screening through the NBCSP.  Current 
smoking (RR=0.86, 0.83-0.90), non-participation in other cancer screening (RR=0.84, 0.81-0.86), poor 
self-reported health (RR=0.89, 0.86-0.91), lower levels of education (RR=0.91, 0.90-0.93), and not 
speaking English at home (RR=0.88, 0.85-0.91) were associated with reduced ever-uptake of 
screening the NBCSP and of any CRC screening. Individuals with a family history of CRC were less 
likely to screen through the NBCSP (RR= 0.71, 0.69-0.73), but more likely to participate in any CRC 
screening (RR= 1.18, 1.17-1.19).   
Smokers, disadvantaged groups and those with non-English speaking backgrounds are less likely to 
have ever-participated in organised screening through the NBCSP or in any form of CRC screening, 
suggesting the need for specific strategies to improve uptake in these groups. 
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Introduction 
Colorectal cancer (CRC) is the second most common cancer in women and third most common 
cancer in men worldwide.1 Australia has one of the highest incidences of CRC worldwide, with age-
standardised rates of 67.6 and 48.8 per 100,000 in men and women respectively in 2013.1 Trials have 
shown that screening with faecal occult blood test (FOBT) is effective at reducing disease-related 
mortality.2   
In Australia, population-based CRC screening is provided through the Australian Government’s 
National Bowel Cancer Screening Program (NBCSP). All citizens and permanent residents of 
Australia, as well as some temporary residents and refugees, receive an invitation letter, free 
immunochemical FOBT (iFOBT) kit and instructions on how to use it soon after they reach an eligible 
age. Different ages were targeted during various phases of the program.  Phase 1 of the program 
went from August 2006 to June 2008 and it targeted people turning 55 and 65 years. Phase 2 went 
from July 2008 to June 2013 and it targeted people turning 50, 55 and 65 years. Phase 3 went from 
July 2013 to July 2015 and it targeted people turning 50, 55, 60 and 65 years. After July 2015, 
progressively more age groups between 50-74 years were invited and by 2020, the fully rolled out 
NBCSP will invite all people aged 50-74 years to screen with iFOBT every two years.  
Participation rates in the NBCSP for those age cohorts invited to screen have remained at below 40% 
in the 10 years following commencement of rollout.3 4 Analyses of the NBCSP produced by the 
Australian Institute of Health Welfare (AIHW) have shown lower rates of participation in younger 
invitation age groups, in people from the lower socioeconomic groups and in people living in remote 
areas. 3 4  
The rollout of the NBCSP is being implemented in the context of some level of opportunistic or de 
facto screening. In Australia, FOBT can be accessed via primary care physicians or available for 
purchase from pharmacies and non-government organisations. Colonoscopy is a procedure to 
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visually examine the bowel and is commonly performed to follow-up of positive screening results, 
screening and surveillance of colorectal polyps and cancers, and diagnosis or treatment of 
gastrointestinal conditions. It is widely available throughout Australia’s public and private hospitals, 
with fees for the provision of colonoscopy services subsidised by the Australian government through 
the Medicare Benefits Schedule (MBS). There has been a marked growth in the provision of 
colonoscopies in Australia, with demand for MBS-funded colonoscopy (28% increase between 2009-
10 and 2014-15) outstripping  population growth (8% increase over the same period).5 Although 
follow-up of positive results from the NBCSP can account for some of the increases in MBS-funded 
colonoscopy, it is probable that a substantial proportion of the procedures are being conducted as 
de facto screening tests.  
The extent of out-of-program screening and the influence of sociodemographic factors other than 
those collected by the NBCSP on screening uptake are largely unknown. Furthermore, screening 
behaviour in relation to risk factors for CRC has not been characterised. A family history of CRC, 
smoking,6 obesity, 7 alcohol consumption8 are associated with increased risk for CRC. Observational 
studies have also shown that intake of red and processed increases the risk for CRC,9 while a diet 
high in fruits and vegetables is associated with protection from CRC.10 
 
In this context, therefore, the aim of the current analysis was to identify factors associated with CRC 
screening uptake using prospectively collected individual data in a large cohort study of people aged 
45 years and over residing in Australia’s most populous state (New South Wales, population 7.70 
million).  
 
Methods 
Study population 
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The 45 and Up study cohort includes 267,153 adults aged 45 and over, residing in New South Wales 
(NSW), Australia. Prospective participants were sampled from the enrolment database of the 
Department of Human Services (formerly Medicare Australia), which administers Australia’s publicly 
funded health insurance scheme. The conduct of the 45 and Up Study was approved by the 
University of New South Wales Human Research Ethics Committee.  Information regarding the 
establishment and recruitment of the cohort is described elsewhere.11  
Individuals joined the study in 2006-2009 by completing a questionnaire about sociodemographic, 
medical and lifestyle factors, and provided signed consent for long-term follow-up through repeated 
data collection. A follow-up questionnaire was mailed to participants in 2012-2015, a median of 5.2 
years (SD 1.4 years) after recruitment, to determine how their health and lifestyles had changed 
over time. In the follow-up questionnaire, participants were asked: ‘Have you ever been screened 
for colorectal (bowel) cancer?”. The screening tests encompassed in this question were FOBT, 
sigmoidoscopy and colonoscopy. They were further asked “Were you tested because you received 
an invitation to be screened for bowel cancer as part of the National Bowel Cancer Screening 
Program?” Using the respondent’s month and year of birth, an individual was assumed to have 
received an invitation from the NBCSP if he/she was in an eligible birth cohort invited to screen as 
part of the NBCSP rollout, prior to completion of the questionnaire. Figure 1 shows the timing of the 
NBCSP rollout by age cohort in relation to the follow-up questionnaire. 
 
Exposures assessed 
Data on age, self-rated health status, CRC screening behaviour, screening for other cancers (breast 
cancer screening in women and prostate cancer testing in men), and factors associated with an 
increased CRC risk (family history of CRC, smoking status, alcohol consumption, obesity, physical 
activity and diet) were derived from the follow-up questionnaire. Data on sociodemographic factors, 
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including gender, geographical remoteness of residence as measured by Accessibility-Remoteness 
Index of Australia Plus, socioeconomic disadvantage as measured by the Socio-Economic Indexes for 
Areas (SEIFA), education attainment, language spoken at home and country of birth were derived 
from information collected at the baseline questionnaire.  Health insurance status was derived from 
information collected at the follow-up questionnaire.  
 
Statistical methods 
This analysis uses questionnaire data from 105,897 participants who had responded to the follow-up 
questionnaire by February 2016. Poisson’s regression with robust variance estimation was used to 
estimate the relative risk (RR) of ever-screening through the NBCSP among the study participants 
eligible for an invitation from the NBCSP prior to completion of the follow-up questionnaire,  and of 
ever-screening for CRC among all the study participants who completed the follow-up 
questionnaire.12 The dependent variables were uptake of CRC screening through the NBCSP (yes vs. 
no) in the first model and uptake of any CRC screening (yes vs. no) in the second model. Both models 
included the following independent variables:  sociodemographic factors known to be associated 
with NBCSP participation(age, gender, geographical remoteness of residence, SEIFA) and those that 
were the focus of the current analysis (education, language spoken at home, migrant status and 
health insurance coverage), health factors (family history of CRC, body mass index, self-perceived 
health status,) and health behaviours (smoking status, alcohol intake, physical activity, dietary intake 
of red meat, processed meat, fruit and vegetables, as well as attendance at other cancer screening). 
Analyses relating to ever-screening through the NBCSP were additionally adjusted for the number of 
invitations a person was eligible to receive, while analyses relating to ever-screening for CRC were 
additionally adjusted for eligibility to receive an invitation from the NBCSP. Missing indictor 
categories were created for dependent variables.  A χ2 test for trend was used to test for significance 
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across exposure levels where appropriate. All analyses were performed using SAS® 9.4 (SAS Institute 
Inc., Cary, N.C.). 
 
Results 
Of the 105,897 study participants who had completed the 45 and Up Study follow-up questionnaire, 
13,926 were excluded from the analysis due to completely missing information on CRC screening 
behaviour, leaving 91,968 for analyses. Of these, 70,444 (76.6%) reported ever-screening for CRC 
(Table 1), including 32,324 (79.6%) men and 38,120 (74.2%) women. The proportion of study 
participants who reported ever-screening for CRC was highest in those aged 65-70 years (84.8%) and 
lowest in those aged 70 years and above (71.7%). Ever-participation in CRC screening was highest in 
those living in the least socioeconomically disadvantaged areas (80.0%) and lowest in those living the 
most socioeconomically disadvantaged areas (72.1%).  
Among the 91,968 study participants with information on CRC screening behaviour, 63,777 were 
eligible for invitation from the NBCSP as it was rolled-out (Table 1). Of the 63,777 participants invited 
to participate in the NBCSP, 19% (11,810) had never undergone any CRC screening. 33,148 reported 
ever-screening through the NBCSP, which represents 36.0% of the entire study cohort and 52.0% of 
the study participants eligible for an invitation from the NBCSP. Of the study participants eligible for 
a NBCSP invitation, the proportion of people who reported ever-screening through the NBCSP was 
highest in those aged 55-59 years (54.8%), followed closely by those aged 60-64 years (52.3%), 65-70 
years (52.1%) and 50-54 years (51.2%); it was lowest in those aged 70 years and above (46.3%). In 
each 5-year age group, the proportion of study participants who reported ever-screening through 
the NBCSP was greater in those who had received two invitations than those who had only received 
one. Ever-screening through the NBCSP was highest in those living in the least socioeconomically 
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disadvantaged (53.0%) and lowest in those living in the most socioeconomically disadvantaged areas 
(49.8%).   
Lower levels of education and speaking a language other than English at home were associated with 
reduced uptake of CRC screening (Table 2). However, birth outside of Australia was not significantly 
associated with screening. Private health insurance coverage was not associated with ever-screening 
through the NBCSP (RR=1.02, 1.00-1.04 for those without vs. with private health insurance), but 
people without private health insurance were less likely to have had any CRC screening (RR=0.93, 
0.92-0.94 for those without vs. with private health insurance). Compared to study participants with 
no family history of CRC, those with a family history were less likely to have had screening through 
the NBCSP (RR=0.71, 0.69-0.73), but were more likely to have had any CRC screening (RR=1.18, 1.17-
1.19).  
Current smokers were less likely to have ever had any CRC screening (RR=0.90, 0.870-0.92) and to 
screen through the NBCSP (RR=0.88, 0.83-0.92) than those who do not currently smoke (Table 3). 
However, body mass index and health behaviours such as physical activity, alcohol consumption and 
dietary intake of red meat, processed meat, fruit or vegetables did not have significant associations 
with uptake of CRC screening. People who did not attend screening for other cancers were less likely 
to participate in CRC screening, either through the NBCSP (RR=0.84, 0.81-0.86) or in any CRC 
screening (RR=0.79, 0.78-0.81), compared to those reporting they attended screening for other 
cancers. Those with poor or fair levels of self-rated health were less likely to participate in the NBCSP 
(RR=0.89, 0.86-0.91) compared to those with good or excellent levels of self-rated health, but self-
reported health status had no significant relation to uptake of any CRC screening (RR=1.01, 0.99-
1.02).  
Of the 63,777 study participants who were eligible for an invitation from the NBCSP as it was rolled 
out, 33,148 (52.0%) reported ever-screening through the NBCSP and 18,819 (29.5%) reported ever-
screening outside of the NBCSP. In those who ever-screened outside of the NBCSP, 10,572 (56.2%) 
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reported use of colonoscopy alone, 2691 (14.3%) reported use of FOBT alone, and 5278 (28.1%) 
reported used of both FOBT and colonoscopy, possibly as a result of diagnostic colonoscopy 
following positive FOBT and subsequent surveillance colonoscopy. Use of colonoscopy only in those 
who were eligible for NBCSP invitation but reported testing outside of the program was significantly 
associated with having private health insurance (RR=1.06, 1.03-1.11) and a family history of CRC 
(RR=1.24, 1.21-1.27).“  
Overall, there were no significant gender differences in the associations between CRC screening and 
education, language, health insurance coverage, health status and health behaviours (Figure 2A-B).   
 
Discussion 
We report the first comprehensive assessment of factors associated with ever-participation in CRC 
screening, either through a national population-based organised screening program, the NBCSP, or 
in any form of CRC screening. Individuals who were current smokers, did not attend screening for 
other cancers, had lower levels of education and did not speak English at home were less likely to 
have ever-participated in the NBCSP; these health behaviours and sociodemographic inequities were 
also associated with decreased likelihood of ever-participation in any CRC screening.  Family history 
of CRC was associated with reduced uptake up organised screening through the NBCSP, but 
increased uptake of any CRC screening. Private health insurance coverage was not associated with 
ever-participation in the NBCSP, but those without private health insurance coverage were less likely 
to have had any CRC screening.  
Our findings for the influence of health behaviours on CRC screening participation add to the limited 
evidence available. Studies based on CRC screening programmes in England, Finland and France, 13-15 
as well as studies of CRC screening in the United States16 17 have found similar associations between 
current smoking and non-participation in CRC screening. Our study did not find significant 
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associations between obesity and CRC screening uptake. Although earlier studies had found that 
being overweight or obese was associated with reduced participation in CRC screening, 18-20 more 
recent studies suggest that the prevalence of up-to-date CRC screening has increased in the last 
decade, and that being obese was associated with increased odds of CRC screening. 21 22 However, 
direct comparisons to our findings may be may be limited due to differences in health services 
delivery, as most other studies have been based on the U.S. population where CRC screening is 
conducted through physician recommendations.    
Findings from our study and others have shown that screening behaviour for other cancers is 
predictive of participation in CRC screening; women who do not participate in breast cancer 
screening were less likely to undergo CRC screening, and men who do not participate in prostate 
cancer testing were less likely to undergo CRC screening. 16 23 Other health behaviours, such as 
regular physical exercise or dietary consumption of fruits, vegetables, red or processed meats were 
not found to be associated with participation. Participants who felt that their overall health were fair 
or poor were less likely to have had screening through the NBCSP compared to those with better 
ratings, possibly due to there being competing health priorities in those with poorer levels of health.  
Multiple studies have shown that individuals from ethnic minorities are less likely to undergo 
screening for CRC, breast and cervical cancers, 24 25 and that language barrier was a key factor in 
screening disparities.26-28 Our findings are consistent with these studies and provide the first 
individual-level evidence for language being a significant barrier to participation in the NBCSP in a 
large population-based study cohort. An earlier survey of 121 Australians from five culturally distinct 
groups found that individuals who are non-English speaking could not read the NBCSP invitation or 
understand the instructions for iFOBT sample collection, nor did they know that translations were 
available from the NBCSP website.26 Therefore, culturally and linguistically appropriate interventions 
are required to improve screening participation in those from non-English-speaking backgrounds.  
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In our study, the proportion of people reporting ever having CRC screening is substantially higher 
than the proportion that ever ever-screening through the NBCSP (76.6% vs. 36.0%). This suggests 
that a sizeable proportion of the study population underwent screening outside of the NBCSP, partly 
because many (about one third) were not eligible for an invitation from the NBCSP as it was rolling 
out for the period covered by our analysis. With plans for the NBCSP to implement biennial iFOBT to 
all Australians aged 50-74 years by 2020, the number of invitations to screen through the NBCSP will 
increase considerably in the next three years.29 In this environment, out-of-program screening may 
result in underutilisation of organised screening, cause duplication of services and potentially 
increase the cost of CRC screening. 
Individuals with a family history of CRC may be more likely to engage in out-of-program screening, as 
our study found that individuals with a family history of CRC were more likely to undergo any CRC 
screening, but were less likely to screen through the NBCSP.  A family history of CRC was also 
associated with use of colonoscopy alone in those who were eligible for an invitation from the 
NBCSP but reported testing outside of the program.  In Australia, CRC screening guidelines for those 
with a family history of CRC are based on an assessment of the increased risk of CRC attributable to 
family history.30  The latest revision of the Australian CRC screening guidelines, currently in draft, 
relates screening recommendations to absolute levels of risk based on the number of cancer 
affected family members, whether they are first-degree relatives and the age of onset of CRC in the 
relatives.31  In particular, it seeks to discourage screening by colonoscopy in individuals who are 
categorised as ‘slightly above average risk’ of CRC, defined as having one first-degree or second-
degree relative diagnosed with CRC at age 55 years or older. 31 This group, which constitutes the 
majority of individuals who have family history of CRC, have up to 2-fold the risk of CRC, a risk 
increase which the guidelines suggest do not warrant CRC screening by colonoscopy. 31 
Studies based on non-government funded CRC screening programmes have consistently shown that 
absence of health insurance coverage is associated with reduced uptake of CRC screening.15 32-35 In 
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Australia, private health insurance supplements the federally-funded Medicare system and provides 
cover against some or all the costs associated with inpatient and outpatient medical treatments.36 
Rates of private health insurance coverage are substantially lower in people from the lowest 
socioeconomic areas  compared to people from the highest socioeconomic areas (33% vs.79%).37 In 
our study, absence of private health insurance coverage was not associated with reduced ever-
screening through the NBCSP, but those without private health insurance were less likely to have 
had any CRC screening. This indicates that the provision of free, population-based CRC screening 
through the NBCSP is effective in addressing one of the key socioeconomic factors associated with 
reduced CRC screening.  
The proportion of study participants who reported ever-screening through the NBCSP cannot be 
directly compared with NBCSP data for several reasons. Our study looked at ever-screening through 
the NBCSP, whereas participation rates reported by the program are for people invited to screening 
within the preceding 24 months. Our study participants were divided into 5-year age groups based 
on their age at the time of follow-up questionnaire completion, and each 5-year age group is 
comprised of a varying mixture of people who were eligible for one or two invitations from the 
NBCSP at different ages. Therefore, the proportion of participants who reported ever-screening in 
the NBCSP differs to the participation rates in the various invitation age groups reported by the 
NBCSP.  
In common with virtually all cohort studies, the 45 and Up Study cohort is more health conscious 
than the general population, and a previous study found that there was an overall tendency of 
colorectal test uptake to be associated with health-conscious behaviours. 38 Therefore, uptake of 
CRC screening in our study is likely to be greater than the general population and that absolute 
percentages found here are unlikely to be representative of the general population. Our finding of 
men having higher rates of ever-screening through the NBCSP than women differs from population-
based participation rates reported by the NBCSP3 4 39. This may be explained by a greater differential 
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in the health-seeking behaviour between study participants and the general population for male 
participants than female participants. Nevertheless, comparisons from within the cohort, including 
the relative risks on factors affecting uptake of screening or its outcomes presented here, should 
remain valid even when the cohort is from a selected group.40  
A limitation of our study is that screening history was derived from self-reported data, which could 
be affected by biases related to the accuracy of recall about screening history and to the social 
desirability of certain responses, potentially resulting in inaccurate reporting of screening.41 A meta-
analysis of validation studies on self-reported cancer screening uptake in the United States found 
that self-reported versus documented history of FOBT and colorectal endoscopy had reasonably high 
sensitivity (0.82 and 0.79, respectively) and specificity (0.78 and 0.90).42 A survey of people living in 
England showed that self-reported ever uptake of CRC screening through the National Health Service 
Bowel Cancer Screening Programme was 94% accurate.43 There may also be concern that although 
the questionnaire specifically asked about ‘screening’, participants may not be able to distinguish 
the difference between a screening and diagnostic test. However, a previous study has shown that 
most individuals who correctly recalled the testing history also accurately identified the reason for 
testing, with concordance of 80% for FOBT and 70% for endoscopy.44 Furthermore, the associations 
we reported involving the NBCSP are likely to be specific to screening.  
The use of prospectively collected personal data in a large cohort study brings new insight into 
factors related to participation in CRC screening, and specifically, screening through the NBCSP. The 
findings here demonstrate the influence of health behaviours on CRC screening uptake, which is 
important as behavioural risks for CRC may be compounded by reduced uptake of screening. 
Strategies to incorporate CRC screening into health promotion initiatives targeting smoking and 
obesity may help to improve screening uptake in individuals with behavioural risks for CRC. The 
study findings also suggest that although there continues to be sociodemographic disparities in CRC 
screening participation, some are ameliorated by the implementation of a national population-based 
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screening program. However, disadvantaged groups and those from non-English-speaking 
backgrounds have reduced participation in the screening program, and further strategies to improve 
uptake in these groups are encouraged.  
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Table 1: Ever-uptake of CRC screening through the NBCSP and of any CRC screening, by 
sociodemographic characteristics of 45 and Up study participantsa 
  
                                                          
a
 Variables are derived from responses to the 45 and Up baseline questionnaire, unless stated otherwise 
b
 For each variable, the numbers of participants with missing responses are not shown. 
c
 33,148 of 63,777 reported ever-screening through the NBCSP, which represents 36.0% of the entire study 
cohort and 52.0% of the study participants eligible for an invitation from the NBCSP.  
  
CRC screening through the 
NBCSP 
 
 Any CRC screening  
(includes screening 
outside the NBCSP) 
  
Total number 
eligible for NBCSP 
invitation 
% 
screened 
 Total 
number 
eligible 
% 
screened 
Gender 
 Male 26985 55.3%  40580 79.6% 
Female 36792 49.6%  51388 74.2% 
Age at follow-up 
  
 
  50 – 54 11203 51.2%  11341 73.2% 
 
One NBCSP invitation 11114 51.1%  
  
 
Two NBCSP invitations 89 56.2%  
  55 – 59 16895 54.8%  16896 80.4% 
 
One NBCSP invitation 13427 50.7%  
  
 
Two NBCSP invitations 3468 70.8%  
  60 – 64 10927 52.3%  18262 75.3% 
 
One NBCSP invitation 7215 44.7%  
  
 
Two NBCSP invitations 3712 67.1%  
  65 – 70 16891 52.1%  16892 84.8% 
 
One NBCSP invitation 16860 52.1%  
  
 
Two NBCSP invitations 31 67.7%  
  70+ 7861 46.3%  28577 71.7% 
 
One NBCSP invitation 7639 45.9%  
  
 
Two NBCSP invitations 222 59.5%  
  Area of residence  
Metropolitan areas 32154 51.1%  46498 75.9% 
Non-metropolitan areas 31623 52.9%  45470 77.3% 
Socio-Economic Indexes for Areas (SEIFA)  
 Least disadvantaged (quintile 5) 15508 53.0%  21490 80.0% 
Second least disadvantaged (quintile 4) 11622 52.8%  16250 78.2% 
Middle (quintile 3) 12154 52.3%  17399 76.5% 
Second most disadvantaged (quintile 2) 12264 52.2%  18201 75.1% 
Most disadvantaged (quintile 1) 10304 49.8%  15912 72.1% 
Total
b
 63777 52.0%
c
  91968 76.6%  
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Table 2: Comparison of factors associated with ever-uptake of screening through the NBCSP and of 
any CRC screening, among participants of the 45 and Up Studya  
 
CRC screening through the NBCSP
b
 
 
 
Any CRC screening
c
 
(includes screening outside the NBCSP) 
Variable Total n
d
 % screened RR (95% CI) 
 
Total n % screened RR (95% CI) 
Education level  
Post-high school 
qualifications 41917 54.3% 1.00 
 
57306 79.9% 1.00 
Up to and including HSC 21452 47.6% 0.91 (0.90 - 0.93) 
 
33894 71.4% 0.94 (0.93 - 0.94) 
Language spoken at home  
English only 59600 52.3% 1.00 
 
86108 77.4% 1.00 
Non-English 4177 46.8% 0.88 (0.85 - 0.91) 
 
5863 65.5% 0.89 (0.87 - 0.90) 
Country of Birth 
Australia 50256 51.9% 1.00 
 
71911 77.7% 1.00 
Overseas 13281 52.2% 1.02 (1.00 - 1.04) 
 
19614 72.8% 0.97 (0.96 - 0.98) 
Private health insurance at follow-up 
No  15539 50.6% 1.00 
 
66592 79.5% 1.00 
Yes 47275 52.5% 1.02 (1.00 - 1.04) 
 
23636 68.8% 0.93 (0.92 - 0.94) 
Family history of bowel cancer at follow-up 
No 53773 54.4% 1.00  77029 74.3% 1.00 
Yes 9984 38.8% 0.71 (0.69 - 0.73)  14877 88.6% 1.18 (1.17 - 1.19) 
 
 
 
 
 
 
 
 
 
  
                                                          
a
 Variables are derived from responses to the 45 and Up baseline questionnaire, unless stated otherwise 
b
 Model included independent variables gender, age, number of invitations received from the NBCSP, area of residence, 
SEIFA, education, language spoken at home, country of birth, private health insurance status, family history of bowel 
cancer, self-reported health status, screening for other cancers, smoking status, alcohol consumption, physical activity, BMI, 
as well as dietary intake of processed meat, red meat, fruits and vegetables.  
c
 Model included independent variables gender, age, eligibility to receive an invitation from the NBCSP, area of residence, 
SEIFA, education, language spoken at home, country of birth, private health insurance status, family history of bowel 
cancer, self-reported health status, screening for other cancers, smoking status, alcohol consumption, physical activity, BMI, 
as well as dietary intake of processed meat, red meat, fruits and vegetables.  
d
 For each variable, the number of participants with missing responses are not shown.  
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Table 3: Health behaviours and health factors associated with ever-uptake of CRC screening 
through the NBCSP and of any CRC screening, among participants of the 45 and Up studya  
 
CRC screening through the NBCSP
b
 
 
 
Any CRC screening
c
 
(includes screening outside the NBCSP) 
Variables Total n
d
 % screened RR (95% CI) 
 
Total n % screened RR (95% CI) 
Screening for other cancers 
       Yes 56946 52.7% 1.00 
 
81669 78.5% 1.00 
No 6397 45.3% 0.84 (0.81 - 0.86) 
 
9390 60.6% 0.79 (0.78 - 0.81) 
Smoking status 
       Not current smoker 60396 52.4% 1.00 
 
87634 77.1% 1.00 
Current smoker 3014 43.8% 0.86 (0.83 - 0.90) 
 
3660 65.4% 0.89 (0.86 - 0.91) 
Alcohol consumption 
≤ 14 drinks/week 35348 53.2% 1.00 
 
49765 78.5% 1.00 
> 14 drinks/week 9334 52.8% 0.98 (0.96 - 1.00) 
 
12394 81.1% 1.01 (1.00 - 1.02) 
Non-drinkers 18269 49.5% 0.98 (0.97 - 1.00) 
 
28186 72.1% 0.97 (0.96 - 0.98) 
Physical activity
e
 
       Meets guidelines 46841 52.8% 1.00 
 
67079 77.8% 1.00 
Does not meet guidelines 16936 49.7% 0.96 (0.95 - 0.98) 
 
24892 73.5% 0.98 (0.97 - 0.98) 
Body Mass Index (kg/m
2
) 
Not overweight (< 25) 25064 53.0% 1.00 
 
36069 77.2% 1.00 
Overweight (≥ 25) 31658 51.6% 0.95 (0.93 - 0.97) 
 
44754 77.3% 0.97 (0.96 - 0.98) 
Consumption of processed meat 
      ≤ 1 serve/week 43610 51.5% 1.00 
 
62530 76.5% 1.00 
> 1 serve/week 19812 52.9% 1.01 (0.99 - 1.03) 
 
28756 76.7% 0.99 (0.99 - 1.00) 
Consumption of red meat 
       ≤ 2 serves/week 26163 50.9% 1.00 
 
37237 75.2% 1.00 
> 2 serves/week 37234 52.8% 1.03 (1.01 - 1.05) 
 
54012 77.5% 1.01 (1.00 - 1.02) 
Consumption of fruit 
       < 2 serves/day 17578 51.1% 1.00 
 
24129 76.0% 1.00 
≥ 2 serves/day 44597 52.5% 1.02 (1.00 - 1.04) 
 
65487 77.0% 1.01 (1.00 - 1.02) 
Consumption of vegetables 
       < 5 serves/day 41243 52.3% 1.00 
 
58538 76.7% 1.00 
≥ 5 serves/day 21602 51.6% 1.01 (0.99 - 1.03) 
 
31853 76.8% 1.01 (1.00 - 1.01) 
Self-rated health status        
Good or excellent 56776 52.8% 1.00  79826 77.3% 1.00 
Fair or poor 6406 44.3% 0.89 (0.86 - 0.91)  10993 71.7% 1.01 (0.99 - 1.02) 
 
 
                                                          
a
 Variables are derived from responses to the 45 and Up follow-up questionnaire 
b
 Model included independent variables number of invitations received from the NBCSP, gender, age, area of residence, 
SEIFA, education, language spoken at home, country of birth, private health insurance status, family history of bowel 
cancer, self-reported health status, screening for other cancers, smoking status, alcohol consumption, physical activity, BMI, 
as well as dietary intake of processed meat, red meat, fruits and vegetables. 
c
 Model included independent variables gender, age, eligibility to receive an invitation from the NBCSP, area of residence, 
SEIFA, education, language spoken at home, country of birth, private health insurance status, family history of bowel 
cancer, self-reported health status, screening for other cancers, smoking status, alcohol consumption, physical activity, BMI, 
as well as dietary intake of processed meat, red meat, fruits and vegetables. 
d
 For each variable, the number of participants with missing responses are not shown.  
e
 Australia’s Physical Activity and Sedentary Behaviour Guidelines44
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Figure 1 
Caption:  
Figure 1. National Bowel Cancer Screening Program Age Eligibility by Year of Birth  
Legend:  
Figure 1 shows the timing of the NBCSP rollout for specific age cohorts and mailout of the follow-up 
questionnaire from the 45 and Up study.  
 
Figure 2A-B 
Caption: 
Figure 2A. Comparison of factors associated with CRC screening through the NBCSP in men and 
women from the 45 and Up study# 
Figure 2B. Comparison of factors associated with any CRC screening in men and women from the 45 
and Up study# 
 
Legend: 
Figure 2A shows a comparison of factors associated with CRC screening through the NBCSP in men 
and women from the 45 and Up study. Figure 2B shows a comparison of factors associated with any 
CRC screening in men and women from the 45 and Up study.  
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Highlights 
- Smokers were less likely to have ever-screened for CRC  
- Those who were less likely to screen for breast cancer (or have PSA testing) to have ever-
screened for CRC 
- Lower levels of education and non-English speakers were associated with lower uptake of 
CRC screening  
- Private health insurance coverage was not associated with uptake of screening through the 
NBCSP 
- A sizeable proportion of the study population underwent some form of CRC testing outside 
of the NBCSP  
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